Mark Brazier

Mark Brazier is an experienced compliance and quality assurance professional with a diverse background in the biotechnology and pharmaceutical industries. Currently serving as the Group Head of Compliance at Polpharma Biologics since March 2021, Mark has held significant roles at prominent companies including Sanofi as the Biologics Compliance & Quality Programme Lead and Mentor, and as a project manager for FDA inspections at DBV Technologies. Mark's career includes leadership positions focusing on FDA readiness and quality transformation across various organizations, demonstrating expertise in compliance and quality management. Educational credentials include degrees in Computer System Auditing and Environmental Management, complemented by certifications in ISO9001 auditing.